Dominik Höchli
Directeur/Membre du Conseil chez MOLECULAR PARTNERS AG
Postes actifs de Dominik Höchli
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOLECULAR PARTNERS AG | Directeur/Membre du Conseil | 21/04/2021 | - |
| Independent Dir/Board Member | 21/04/2021 | - | |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Directeur Général | 01/01/2021 | - |
Historique de carrière de Dominik Höchli
Anciens postes connus de Dominik Höchli
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AbbVie AG | Corporate Officer/Principal | - | - |
Formation de Dominik Höchli
| University of Bern | Doctorate Degree |
Statistiques
Internationale
| Suisse | 4 |
| Pays-Bas | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
| AbbVie AG |
- Bourse
- Insiders
- Dominik Höchli
- Expérience